Tag Archives: COPD

Introduction to Functional Respiratory Imaging (FRI) for Investors and Market Analysts

For those who cannot attend our event coming Thursday at Flanders House in New York, you are welcome to register for the Webcast via following link:

https://attendee.gotowebinar.com/register/8186175617140384514

 

 

 

FLUIDDA is delighted to invite you to a dedicated session discussing her proprietary Functional Respiratory Imaging (FRI) technology and its application in drug and device development.

During the presentation FLUIDDA’s CEO, Dr. Jan De Backer, will present the technology and explain how it can be used to assess the potential of new respiratory drugs and devices. Some recent examples in Idiopathic Pulmonary Fibrosis (IPF) and Chronic Obstructive Pulmonary Disease (COPD) will be highlighted and an update on the regulatory status of FRI will provided.

The primary target audience for the session consists of market analysts and investors, however anyone with an interest in therapeutic development in respiratory medicine is welcome to register.

Kindly register by providing the following information, seating is limited:

Fields marked with an * are required

 

FLUIDDA’s FRI Technology was used in a Positive Phase II Trial with iNOpulse® for Treatment of Pulmonary Hypertension (PH) Associated with Chronic Obstructive Pulmonary Disease (COPD)

“Functional Respiratory Imaging (FRI) provided valuable insights throughout the development process of iNO in COPD patients with PH. The therapy was effective in the initial studies and has great potential to improve the lives of these severely affected patients” Dr. J. De Backer, CEO FLUIDDA   Changes in Blood Vessel Volume determined using Functional Respiratory… Continue Reading

FLUIDDA’s FRI technology will shine throughout ERS 2017

As the European Respiratory Society Conference is approaching rapidly, FLUIDDA is proud to announce that a total of 9 abstracts will be presented, highlighting the power of Functional Respiratory Imaging (FRI). FRI capabilities will be presented over a range of applications including: drug delivery optimization bronchodilation and non-invasive ventilation in COPD bronchoconstriction in asthma disease… Continue Reading

Study demonstrates validity and utility of FRI-based V/Q

Exciting new results will be presented at the upcoming European Respiratory Society Conference in Milan from 9-13 September! The primary function of the respiratory system is the transfer oxygen from the environment into the blood stream of a individual. Consequently in a healthy subject the regional ventilation in the lungs is well matched to the… Continue Reading

ATS 2016 : FLUIDDA presents 7 abstracts in the scientific program.

FLUIDDA’s mission: improving the health of respiratory patients ATS 2016 contribution: 7 abstracts in the scientific program. Tuesday, May 17, 2016 Room 304 (South Building, Esplanade Level): Session C23: 9:00 AM-11:00 AM Poster Discussion: Contemporary Questions in Lung Transplantation Assessment of FEV1 decline after lung transplantation using Functional Respiratory Imaging Area D, Hall D, P406… Continue Reading

Fluidda NV

Groeningenlei 132

2550 Kontich

Belgium

BE 0877 160 706

Tel: +32/(0)3 450 87 20

Fax: +32/(0)3 450 87 29

info@fluidda.com

Fluidda NV

Groeningenlei 132

2550 Kontich

Belgium

BE 0877 160 706

Tel: +32/(0)3 450 87 20

Fax: +32/(0)3 450 87 29

info@fluidda.com

FLUIDDA, Inc

675 US Highway One
North Brunswick, NJ 08902
United States

FLUIDDA, Inc

675 US Highway One
North Brunswick, NJ 08902
United States

FLUIDDA India

Medical Imaging pvt ltd
A-95/96, DGP Nagar -2, Ambad
Nashik 422010
India

FLUIDDA India

Medical Imaging pvt ltd
A-95/96, DGP Nagar -2, Ambad
Nashik 422010
India

All content © FLUIDDA 2017